Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Mabs|May 5, 2011
Conformational stability and aggregation of therapeutic monoclonal antibodies studied with ANS and Thioflavin T bindingVeysel Kayser, Naresh Chennamsetty, Vladimir Voynov, et al.Proteins|February 3, 2011
Prediction of protein binding regionsNaresh Chennamsetty, Vladimir Voynov, Veysel Kayser, et al.The Journal of Physical Chemistry. B|April 24, 2010
Prediction of aggregation prone regions of therapeutic proteinsNaresh Chennamsetty, Vladimir Voynov, Veysel Kayser, et al.Journal of Molecular Biology|June 17, 2009
Aggregation-prone motifs in human immunoglobulin GNaresh Chennamsetty, Bernhard Helk, Vladimir Voynov, et al.Antibodies (Basel, Switzerland)|November 21, 2020
Discovery Strategies to Maximize the Clinical Potential of T-Cell Engaging Antibodies for the Treatment of Solid TumorsVladimir Voynov, Paul J Adam, Andrew E Nixon, et al.Journal of Fluorescence|October 2, 2010
Tryptophan-tryptophan energy transfer and classification of tryptophan residues in proteins using a therapeutic monoclonal antibody as a modelVeysel Kayser, Naresh Chennamsetty, Vladimir Voynov, et al.Mabs|January 14, 2010
Predictive tools for stabilization of therapeutic proteinsVladimir Voynov, Naresh Chennamsetty, Veysel Kayser, et al.Proceedings of the National Academy of Sciences of the United States of America|July 3, 2009
Design of therapeutic proteins with enhanced stabilityNaresh Chennamsetty, Vladimir Voynov, Veysel Kayser, et al.Journal of Pharmaceutical Sciences|January 27, 2011
Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregationVeysel Kayser, Naresh Chennamsetty, Vladimir Voynov, et al.Biotechnology Journal|October 16, 2010
Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodiesVeysel Kayser, Naresh Chennamsetty, Vladimir Voynov, et al.Pageof 2